HeartBeam 

$1.23
46
+$0+0% Today

Statistics

Day High
1.23
Day Low
1.19
52W High
-
52W Low
-
Volume
36,996
Avg. Volume
-
Mkt Cap
42.37M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Q4 2025
Next
-0.15
-0.14
-0.14
-0.13
Expected EPS
-0.1407
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
0Revenue
-38.9MNet Income

Analyst Ratings

$5.63Average Price Target
The highest estimate is 8.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BEAT.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of medical devices, including cardiovascular devices, competing directly with HeartBeam's heart monitoring technologies.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc specializes in medical technologies, services, and solutions, including cardiac and vascular devices, making it a direct competitor in the heart monitoring space.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including cardiac rhythm management.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Royal Philips offers healthcare solutions including advanced cardiac diagnostics and monitoring technologies, competing in the same space as HeartBeam.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on women's health and well-being through early detection and treatment, including cardiac health, positioning it as a competitor.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. provides a range of clinical diagnostics and life science research products, including those for cardiovascular disease detection.
GE Aerospace
GE
Mkt Cap325.88B
General Electric Company, through its healthcare division, offers medical imaging and monitoring technologies, including those for cardiac care.
Siemens
SIEGY
Mkt Cap224.45B
Siemens Healthineers AG is a major player in the healthcare industry, offering a wide range of medical technologies, including diagnostic and therapeutic solutions for cardiac conditions.
Masimo
MASI
Mkt Cap7.64B
Masimo Corporation is known for its innovative noninvasive monitoring technologies, including pulse oximetry, which can be used in cardiac care.
Resmed
RMD
Mkt Cap36.04B
ResMed Inc. specializes in cloud-connectable medical devices for respiratory disorders but also offers products that can be used in cardiac patient monitoring.

About

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Show more...
CEO
ISIN
US42238H1086

Listings

0 Comments

Share your thoughts

FAQ

What is HeartBeam stock price today?
The current price of BEAT.BOATS is $1.23 USD — it has increased by +0% in the past 24 hours. Watch HeartBeam stock price performance more closely on the chart.
What is HeartBeam stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange HeartBeam stocks are traded under the ticker BEAT.BOATS.
What is HeartBeam market cap?
Today HeartBeam has the market capitalization of 42.37M
When is the next HeartBeam earnings date?
HeartBeam is going to release the next earnings report on May 07, 2026.
What were HeartBeam earnings last quarter?
BEAT.BOATS earnings for the last quarter are -0.14 USD per share, whereas the estimation was -0.14 USD resulting in a -1.82% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HeartBeam revenue for the last year?
HeartBeam revenue for the last year amounts to 0 USD.
What is HeartBeam net income for the last year?
BEAT.BOATS net income for the last year is -38.9M USD.
When did HeartBeam complete a stock split?
HeartBeam has not had any recent stock splits.